Antipsychotics for people with persistent negative symptoms of schizophrenia

  • Protocol
  • Intervention

Authors

  • Craig Whittington,

    Corresponding author
    1. Research Department of Clinical, Education & Health Psychology, University College London, Centre for Outcomes Research and Effectiveness (CORE), London, UK
    • Craig Whittington, Centre for Outcomes Research and Effectiveness (CORE), Research Department of Clinical, Education & Health Psychology, University College London, Gower Street, London, WC1 6BT, UK. c.whittington@ucl.ac.uk.

    Search for more papers by this author
  • Thomas RE Barnes,

    1. Imperial College London, London, UK
    Search for more papers by this author
  • Tim Kendall

    1. Royal College of Psychiatrists Research Unit, National Collaborating Centre for Mental Health, London, UK
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the clinical effects and safety of antipsychotic drugs in comparison with placebo or another antipsychotic drug in the treatment of people with persistent negative symptoms of schizophrenia and schizophrenia-like psychosis.